Biblio Discovery — Demo Discovery Service

4 hasil untuk "Madison C. Laird"

Menampilkan 1–4 · 0,51 detik · RSS

  1. Artikel Jurnal

    Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise

    Genevieve M. Abd; Madison C. Laird; Jennifer C. Ku dkk.

    Frontiers in Oncology, Vol. 13 · 2023 · Inggris · DOAJ Scopus

    Cancer stem cells are a subset of cells within the tumor that possess the ability to self-renew as well as differentiate into different cancer cell lineages. The exact mechanisms by which cancer stem cells arise is still not completely understood. However, current research suggests that cancer stem…

  2. Artikel Jurnal

    Higher doses of eculizumab may be beneficial in paroxysmal nocturnal haemoglobinuria in pregnancy

    Harshank Vishnubhai Patel; Steve Stone; Madison C. Laird dkk.

    European Journal of Case Reports in Internal Medicine, Vol. 12 No. 10 · 2025 · Inggris · DOAJ Scopus

    Introduction: Paroxysmal nocturnal haemoglobinuria (PNH) is a rare bone marrow failure disorder that results in complement-mediated haemolysis (mostly intravascular), thrombosis and bone marrow suppression. Terminal complement inhibitors, such as eculizumab, have improved outcomes in pregnant and…

  3. Artikel Jurnal

    Case Report: Hepatitis and autoimmune hemolytic anemia induced by EBV-associated infectious mononucleosis

    Akram Alnounou; Henry Zou; Madison C. Laird dkk.

    Frontiers in Gastroenterology, Vol. 5 · 2026 · Inggris · DOAJ Scopus

    Epstein-Barr virus (EBV) typically causes infectious mononucleosis, but in rare cases, it may lead to complications such as autoimmune hemolytic anemia (AIHA) and hepatitis. We report the case of an 18-year-old previously healthy female who presented with jaundice, red urine, and arthralgia…

  4. Artikel Jurnal

    FAM193A is a positive regulator of p53 activity

    Maria M. Szwarc; Anna L. Guarnieri; Molishree Joshi dkk.

    Cell Reports, Vol. 42 No. 3 · 2023 · Inggris · DOAJ Scopus

    Summary: Inactivation of the p53 tumor suppressor, either by mutations or through hyperactivation of repressors such as MDM2 and MDM4, is a hallmark of cancer. Although many inhibitors of the p53-MDM2/4 interaction have been developed, such as Nutlin, their therapeutic value is limited by highly…